FRANZE', Maria Stella
 Distribuzione geografica
Continente #
EU - Europa 369
NA - Nord America 327
AS - Asia 69
Totale 765
Nazione #
US - Stati Uniti d'America 327
IE - Irlanda 159
IT - Italia 85
SE - Svezia 85
CN - Cina 28
IN - India 26
PL - Polonia 20
SG - Singapore 10
DE - Germania 8
VN - Vietnam 4
BE - Belgio 3
CZ - Repubblica Ceca 3
FI - Finlandia 3
AT - Austria 1
BD - Bangladesh 1
NO - Norvegia 1
RU - Federazione Russa 1
Totale 765
Città #
Dublin 159
Chandler 106
Nyköping 64
Messina 32
Ashburn 27
Warsaw 20
Hyderabad 19
Princeton 15
Avola 13
Medford 13
New York 12
Ann Arbor 11
Des Moines 10
Dearborn 9
Catania 6
Jacksonville 6
Pune 6
Singapore 6
Pachino 5
Beijing 4
Boardman 4
Bremen 4
Cambridge 4
Dong Ket 4
Jinan 4
Nanjing 4
Nuremberg 4
Brussels 3
Haikou 3
San Mateo 3
Seattle 3
Tianjin 3
Brno 2
Guangzhou 2
Lappeenranta 2
Rome 2
Scandicci 2
Washington 2
Zhengzhou 2
Belpasso 1
Catanzaro 1
Houston 1
Jiaxing 1
Kunming 1
Los Angeles 1
Milan 1
Ningbo 1
Niscemi 1
Norwalk 1
Olomouc 1
Oslo 1
Redwood City 1
Rosolini 1
San Benedetto del Tronto 1
Shenyang 1
Sortino 1
Vienna 1
Woodbridge 1
Yicheng 1
Totale 620
Nome #
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 104
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 66
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 60
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 59
Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment 53
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 51
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 43
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 39
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 38
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 36
The changing scenario of hepatocellular carcinoma in Italy: an update 36
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 34
Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases 33
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 32
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 30
Pattern of macrovascular invasion in hepatocellular carcinoma 26
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 24
null 19
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 15
Natural Course of COVID-19 and Independent Predictors of Mortality 14
Totale 812
Categoria #
all - tutte 3.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 1 0 0 0 1 10 3 0 2 5 7 1
2020/202176 3 1 14 4 11 2 6 2 4 24 1 4
2021/2022126 5 10 2 4 7 6 17 1 4 16 19 35
2022/2023412 23 48 16 28 29 38 6 23 185 3 12 1
2023/2024141 7 16 3 16 9 30 0 6 1 30 4 19
Totale 812